scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1040366190 |
P356 | DOI | 10.1186/S13756-015-0083-2 |
P932 | PMC publication ID | 4600331 |
P698 | PubMed publication ID | 26457183 |
P5875 | ResearchGate publication ID | 282812347 |
P50 | author | Elaine Larson | Q95978139 |
Bevin Cohen | Q100302797 | ||
P2093 | author name string | Jianfang Liu | |
Darcy Ellis | |||
P2860 | cites work | Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis | Q26997364 |
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii | Q28257612 | ||
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 | Q28298371 | ||
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. | Q30580647 | ||
Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database | Q33364766 | ||
Multidrug resistant Acinetobacter | Q33711902 | ||
Using electronically available inpatient hospital data for research | Q34059172 | ||
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. | Q35005719 | ||
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features | Q35369996 | ||
Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal | Q36150941 | ||
The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
A longitudinal study of Acinetobacter in three Australian hospitals. | Q36973909 | ||
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options | Q37150308 | ||
Acinetobacter baumannii: a universal threat to public health? | Q37197580 | ||
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization | Q37302581 | ||
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections | Q37330689 | ||
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system | Q39922949 | ||
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting | Q43758287 | ||
Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences | Q45048702 | ||
Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010. | Q47774926 | ||
Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again. | Q53947167 | ||
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY | Q80301574 | ||
Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes | Q95522530 | ||
P921 | main subject | hospital-acquired infection | Q215509 |
Acinetobacter baumannii | Q3241189 | ||
P304 | page(s) | 40 | |
P577 | publication date | 2015-10-09 | |
P1433 | published in | Antimicrobial resistance and infection control | Q27724377 |
P1476 | title | Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii | |
P478 | volume | 4 |
Q60929371 | A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit |
Q33555383 | Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? |
Q57156864 | The Use of Liquids Ionic Fluids as Pharmaceutically Active Substances Helpful in Combating Nosocomial Infections Induced by New Delhi Strain, and Species |
Q55260699 | Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics. |
Q49321181 | Unsaturated Fatty Acids Affect Quorum Sensing Communication System and Inhibit Motility and Biofilm Formation of Acinetobacter baumannii |
Search more.